About Abner Louissaint, MD, PhD
Dr. Louissaint's clinical and research interests focus on hematopathology and on the molecular characterization of hematological malignancies.
Dr. Louissaint also has an interest in the development of novel approaches and programs for improving pathology graduate medical education. Current work includes the utility of digital imaging and development of web-based applications to enhance the teaching of autopsy and surgical gross pathology.
Clinical Interests:
- Autopsy Pathology
- Hematopathology
Treats:
- Adult
Locations
Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800
Medical Education
- MD, Weill Cornell Medical College
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Hematopathology, American Board of Pathology
- Pathology - Anatomic/Pathology - Clinical, American Board of Pathology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Overview
As a surgical pathologist with a particular interest in hematopathology, my current research is focused on the molecular characterization of particular disease entities, for the purposes of both classification and prediction of prognosis and susceptibility to treatment. I am currently working on two lines of investigation: 1)Characterization of follicular lymphoma with a special focus on pediatric follicular lymphomas and t(14;18) negative follicular lymphomas. 2) Molecular characterization of thymomas and thymic carcinomas.